Singapore markets closed

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
20.850-0.100 (-0.48%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 51.54B
Enterprise value 45.03B
Trailing P/E 7.59
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.41
Price/book (mrq)0.84
Enterprise value/revenue 0.54
Enterprise value/EBITDA 7.29

Trading information

Stock price history

Beta (5Y monthly) 0.57
52-week change 3-9.89%
S&P500 52-week change 322.23%
52-week high 324.200
52-week low 318.480
50-day moving average 321.818
200-day moving average 320.935

Share statistics

Avg vol (3-month) 3719.23k
Avg vol (10-day) 3526.76k
Shares outstanding 5219.9M
Implied shares outstanding 62.42B
Float 8875.33M
% held by insiders 10.00%
% held by institutions 129.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.82
Forward annual dividend yield 43.93%
Trailing annual dividend rate 30.75
Trailing annual dividend yield 33.58%
5-year average dividend yield 43.20
Payout ratio 429.78%
Dividend date 3N/A
Ex-dividend date 413 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 5.34%
Operating margin (ttm)10.12%

Management effectiveness

Return on assets (ttm)3.82%
Return on equity (ttm)11.63%

Income statement

Revenue (ttm)76.83B
Revenue per share (ttm)47.25
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)N/A
EBITDA 5.29B
Net income avi to common (ttm)4.11B
Diluted EPS (ttm)2.760
Quarterly earnings growth (yoy)2.60%

Balance sheet

Total cash (mrq)19.76B
Total cash per share (mrq)12.15
Total debt (mrq)13.8B
Total debt/equity (mrq)35.66%
Current ratio (mrq)1.64
Book value per share (mrq)22.67

Cash flow statement

Operating cash flow (ttm)3.8B
Levered free cash flow (ttm)1.64B